The Stuart-Prower Factor: Utilization of Clotting Factors obtained by Starch-Block Electrophoresis for Genetic Evaluation
- 1 January 1961
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 7 (1), 99-111
- https://doi.org/10.1111/j.1365-2141.1961.tb00322.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The Nature of the Serum Thromboplastic Defect in Patients with Liver DiseaseBritish Journal of Haematology, 1960
- Electrophoretic Studies of the Prower Factor; a Blood Coagulation Factor which differs from Factor VIIBritish Journal of Haematology, 1958
- A Rapid Screening Test for Disorders of Thromboplastin GenerationBritish Journal of Haematology, 1957
- Stuart Clotting Defect. I. Segregation of an Hereditary Hemorrhagic State from the Heterogeneous Group Heretofore Called “Stable Factor” (SPCA, Proconvertin, Factor VII) DeficiencyJCI Insight, 1957
- Stuart Clotting Defect. II. Genetic Aspects of a `New' Hemorrhagic StateJCI Insight, 1957
- A Brain Extract as a Substitute for Platelet Suspensions in the Thromboplastin Generation TestNature, 1954
- The Thromboplastin Generation TestJournal of Clinical Pathology, 1953
- An Improved One-Stage Prothrombin Method*American Journal of Clinical Pathology, 1952
- The Control of Dicumarol Therapy and the Quantitative Determination of Prothrombin and ProconvertinScandinavian Journal of Clinical and Laboratory Investigation, 1951
- The Clinical Application of the Hippuric Acid and the Prothrombin TestsAmerican Journal of Clinical Pathology, 1940